Top InSightive Alternatives

The ARIA® oncology information system is tailored to support both medical and radiation oncology, including proton therapy, ensuring a broad spectrum of functionalities. It facilitates the review and management of clinical images, prescriptions, lab results, quality assurance data, and patient outcomes, among other important information. Cancer staging is automatically aligned with AJCC guidelines, and the system offers flexible management options for toxicities. With a strong focus on interoperability, ARIA enables seamless use of patient data across a variety of devices and platforms. It provides robust support for HL7 and DICOM standards, which simplifies the transfer of patient information between different healthcare facilities. By granting immediate access to patient data, the system empowers healthcare teams to improve their planning capabilities and make real-time adjustments. Additionally, ARIA enhances the effectiveness of image-guided treatment techniques by efficiently utilizing radiographic, fluoroscopic, and cone-beam CT images. The system also keeps track of essential activities for evidence-based Pay-for-Performance programs, all while maintaining compliance with HIPAA regulations. Moreover, ARIA systematically organizes and stores patient data and images, ensuring that healthcare teams remain well-informed and focused on delivering optimal care. This all-encompassing approach not only streamlines workflows but also plays a significant role in improving patient outcomes, ultimately leading to a more effective oncology care experience.

H1 Universe stands out as a cutting-edge platform that utilizes artificial intelligence to optimize the management of healthcare data, granting users access to an unparalleled global repository of healthcare providers (HCPs). By integrating data from a multitude of sources, including public, private, and proprietary databases, H1 Universe delivers critical insights that are essential for clinical trials, medical affairs, and commercialization strategies. This dynamic tool empowers healthcare teams to identify key stakeholders, streamline clinical research processes, and make swift, informed decisions, significantly enhancing overall efficiency within the healthcare sector. Additionally, the platform promotes real-time decision-making and encourages collaboration among healthcare professionals, ultimately leading to better patient outcomes and a more interconnected healthcare community. In doing so, H1 Universe not only transforms data management but also elevates the standard of care provided to patients.

Enhance the quality of your patient interactions by reducing the time spent on electronic health records through the efficient workflows provided by OncoEMR®. This innovative platform is specifically designed for oncology practices, equipped with unique tools like Document Search that can significantly reduce task completion time from several minutes to just seconds. As MIPS evolves, OncoEMR® offers vital resources to help navigate the program effectively, facilitating the collection and reporting of necessary data while supporting workflows and compliance with reporting requirements. Tailored for community oncology settings, OncoEMR® includes features such as NCCN Chemotherapy Order Templates® and up-to-date AJCC disease factors, making it an indispensable resource for diagnostics and treatment planning. Before you start using OncoEMR®, Flatiron will ensure that your current EHR database is migrated smoothly, guaranteeing that you can hit the ground running on your first day. Once the migration is complete, you'll have access to more than 150 preloaded reports, allowing you to gather critical insights into your clinical metrics and operational performance, including patient wait times. This comprehensive set of tools not only boosts operational efficiency but also significantly enhances patient care and outcomes within your oncology practice, ultimately leading to a more effective healthcare environment. With OncoEMR®, the focus remains firmly on the patient, ensuring that care remains a top priority.

Mosaiq acts as a comprehensive oncology information system and electronic medical record platform that manages all facets of cancer care, from initial diagnosis and treatment planning to execution, monitoring, and reporting on outcomes. This platform unifies clinical, operational, and financial data into a single, integrated database, allowing healthcare providers access to complete patient records and fostering collaboration among various specialties such as radiation oncology and medical oncology. Additionally, it streamlines vital workflows including chemotherapy order management, planning and administering radiation therapy, scheduling appointments, billing, and clinical documentation. Users are also provided with decision support tools and customizable workflows, which help optimize routine tasks and improve accuracy in care. By incorporating these features, Mosaiq not only enhances the overall efficiency of cancer care delivery but also ensures that healthcare professionals can provide more coordinated and effective treatment plans for their patients. Ultimately, this leads to improved outcomes and a more patient-centered approach in oncology.

ConcertAI emerges as a leading provider of AI-powered solutions in the healthcare industry, with a significant emphasis on oncology. The company's primary goal is to improve patient outcomes and accelerate insights by utilizing high-quality real-world data, innovative AI technologies, and profound scientific expertise. They offer a comprehensive range of products and services designed to enhance both clinical research and the experiences of patients. Their Real-World Data Products provide extensive and tailored datasets that meet a variety of research requirements for different organizations. By streamlining clinical trial processes, their digital trial solution boosts efficiency, while the Clinical Trial Optimization (CTO) platform harnesses advanced AI capabilities to enhance the design and execution of trials, particularly in oncology and hematology. Furthermore, in collaboration with NeoGenomics, ConcertAI has launched CTO-H, a software-as-a-service (SaaS) offering that focuses on hematological malignancies, delivering advanced research analytics and improving operational workflows. This combination of innovative technologies not only bolsters research capabilities but also plays a crucial role in advancing patient care within challenging medical specialties. Ultimately, ConcertAI's commitment to integrating AI into healthcare is reshaping the landscape of oncology and enhancing overall treatment pathways.

Deeplink Medical has focused its services around the MIRIO platform, which is tailored to meet the diverse needs and scenarios of those involved in medical imaging within the oncology field, applicable in both clinical environments and everyday practice. Our offerings include three distinct yet interrelated solutions: MIRIO, which monitors evaluations of solid tumors and tracks therapeutic responses in oncology patients; a streamlined patient pathway that connects hospital facilities with private medical practices; and an Imaging CRO that specializes in managing imaging data for oncological clinical trials. The creation of our cutting-edge solutions is supported by a scientific board, providing a solid foundation for our offerings. Furthermore, our collaborative workflow platform organizes imaging data and radiological assessments for patients with solid tumors, ensuring real-time data structuring in line with RECIST 1.1 and iRECIST guidelines from the point of data generation at investigation sites. This capability allows for immediate assessments of treatment responses based on recognized international standards, significantly improving the quality and efficiency of oncological patient care. By integrating these services, we strive to deliver a holistic approach that empowers healthcare professionals to achieve the best possible treatment outcomes while keeping pace with the evolving landscape of oncology. This commitment underscores our dedication to advancing patient care in this critical field.

Tempus AI, a leading health tech company located in Chicago, Illinois, is focused on revolutionizing patient care through the integration of advanced artificial intelligence and precision medicine. By harnessing data and AI, the firm aims to develop customized treatment strategies spanning various medical fields, including oncology, cardiology, radiology, and mental health. Their comprehensive platform merges genomic sequencing, clinical data, and AI-driven analytics, thereby providing healthcare professionals and researchers with vital insights. Tempus enhances patient understanding through a variety of testing methodologies, such as tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline testing, as well as tumor-normal matched profiling and minimal residual disease monitoring. In addition, the company presents a fast and reliable platform for test ordering, acquiring patient insights, and integrating AI technologies into medical practice. Their innovative generative AI-enabled clinical assistant further streamlines access to patient insights, improving the efficiency of healthcare delivery. This dedication to leveraging state-of-the-art technology underscores Tempus AI's mission to elevate health outcomes and propel advancements in medical research. Ultimately, Tempus AI strives to be at the forefront of a transformative era in healthcare.

Omda Cytodose is an oncology medication management system developed by Omda, which utilizes clinically validated protocols along with individualized patient parameters to provide safer and more effective treatment for those facing cancer. This groundbreaking solution improves the quality of care for oncology patients by promoting a cohesive and collaborative treatment environment among healthcare providers, including physicians, pharmacists, and nurses. Designed to accommodate a wide spectrum of adult and pediatric cancers, Omda Cytodose supports various treatment modalities such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Originating from a group of clinicians at one of Norway’s leading cancer facilities, the system was launched in 2001 and has since been widely implemented across healthcare sectors in the Nordic countries, facilitating millions of medication orders. With a robust history spanning 15 years characterized by safety, reliability, and stability, Omda Cytodose is carefully tailored with chemotherapy protocols that align with both national and international standards. This ensures that patients are provided with the most current treatment options available, significantly improving their prospects for successful recovery. As a result, the system not only streamlines medication management but also reinforces the importance of interdisciplinary collaboration in cancer care.

Charm Evolution acts as a sophisticated oncology information management platform that streamlines all activities linked to chemotherapy prescribing and administration, enhancing safety, uniformity, and accountability by replacing handwritten orders with carefully tracked digital prescriptions that allow for order modifications and orphan management for accurate waste reporting. It aggregates reliable and secure patient records alongside treatment information from diverse sources into a singular database, thereby promoting informed and effective decision-making at the point of care. In addition, a smart pathway engine automates treatment protocols, optimizes scheduling in line with regimens, and serves both adult and pediatric oncology and hematology through adaptable treatment libraries, protocol validation, and clinical trial management. The platform also features integrated pharmacy management that provides two-way connectivity with compounding facilities, while allowing for the customization of worksheets and labels. Moreover, the scheduling component improves resource utilization and reduces the necessity for patient travel, ultimately enhancing the efficiency of healthcare delivery. By fostering a collaborative framework, this comprehensive system empowers healthcare providers to offer the highest quality of care to their patients while simultaneously streamlining operational workflows.

Inspirata is an AI-powered oncology platform designed to help healthcare organizations optimize their cancer service lines end to end. It enables accurate, complete, and timely cancer reporting to meet state and federal compliance requirements. The platform uses advanced AI and NLP to automate casefinding, tumor classification, and data abstraction in real time. Inspirata unlocks idle clinical data by structuring pathology, radiology, and clinical reports for research and discovery. Built-in workflows improve operational efficiency, reduce staff burden, and enhance care coordination. Real-time trial matching helps increase clinical trial accrual and ensures unbiased access for eligible patients. Patient navigation capabilities support seamless care from diagnosis through treatment and survivorship. Inspirata integrates with EHRs, registries, and research systems using industry standards. Its solutions are continuously updated to reflect best practices and evolving oncology reporting requirements. Used by academic medical centers and cancer programs worldwide, Inspirata improves both clinical outcomes and financial performance. The platform is supported by decades of oncology-focused expertise. Overall, Inspirata helps cancer centers strengthen their reputation, improve quality of care, and accelerate innovation.

Boost the effectiveness and efficiency of cancer treatment across diverse healthcare settings. Created in close collaboration with oncology professionals, iKnowMedSM functions as an electronic health record (EHR) that provides crucial patient data exactly when needed and is accessible from almost any device. With cutting-edge user interface design and an exceptional mobile platform, iKnowMed EHR offers comprehensive point-of-care treatment decision support along with customizable features that integrate smoothly into existing workflows. Equip your patients with extensive clinical support by leveraging a continuously updated database of oncology treatment protocols, drug availability, and clinical outcomes. Access to evidence-based clinical guidelines and pathways is ensured at the moment it is necessary, facilitating timely and effective decision-making. Additionally, keep treatment alternatives up-to-date by incorporating information on treatment costs, insurance coverage, and reimbursement details, thus aiding both patients and healthcare providers in navigating the intricate landscape of cancer care. By adopting these practices, healthcare providers can not only enhance patient outcomes but also streamline the entire treatment process, ultimately leading to a more effective cancer care system. As a result, this comprehensive approach promotes better health for patients and greater efficiency for providers.

Flatiron Health's Evidence Solutions offer a flexible approach to producing real-world evidence, whether in a prospective or retrospective manner, assisting life sciences companies in effectively achieving their oncology research goals. Central to this suite of services is Flatiron Horizon, an integrated platform that harnesses a vast collection of over 5 million anonymized patient records alongside 1.5 billion data points, enhanced by sophisticated curation strategies and specialized machine learning models tailored for specific diseases. This groundbreaking platform is crafted to support multiple stages of the biopharma lifecycle, from initial discovery and clinical study design to regulatory submissions and post-marketing obligations. Moreover, Flatiron's offerings provide personalized real-world data configurations that are specifically designed for oncology, allowing for prospective evidence generation via minimally invasive studies while refining protocols to improve patient identification. The platform also guarantees a smooth transition of data from electronic health records to electronic data capture systems through the capabilities of Flatiron Clinical Pipe, which enhances both research efficiency and effectiveness. Consequently, such advanced functionalities not only elevate Flatiron Health's standing as a frontrunner in the oncology research landscape but also significantly contribute to the utilization of real-world data in improving patient outcomes. By continuously innovating, Flatiron Health remains committed to advancing the field of oncology through data-driven insights.

At the core of careMESH's services is NAVIGATE, a tailored solution that revolutionizes the patient navigation experience. This cutting-edge tool enables care teams to adeptly handle complex care pathways, particularly in oncology and specialty areas, by improving the referral process, reducing patient leakage, and providing enhanced visibility into patient progress and outcomes. NAVIGATE integrates effortlessly into existing clinical workflows, enabling organizations to broaden their navigation initiatives without facing additional administrative burdens. In addition to NAVIGATE, careMESH offers two supportive solutions: CONNECT and SEARCH. CONNECT ensures secure, role-based communication between various organizations, empowering care teams to collaborate more efficiently without relying on outdated or disjointed communication systems. On the other hand, SEARCH provides users with real-time insights into provider information, making it easier to identify suitable specialists, services, and referral paths both within and among multiple networks. Collectively, these tools form a robust ecosystem that not only enhances patient care but also streamlines operational processes, ultimately leading to better health outcomes. With such a comprehensive approach, careMESH positions itself as a leader in transforming healthcare navigation.

Carevive offers a comprehensive cancer care management platform that is seamlessly integrated with electronic health records (EHR), designed to enhance patient outcomes throughout the entire cancer treatment continuum. The platform's innovative features simplify treatment planning by collecting patient preferences, assessing interest in clinical trials, and addressing both physical and psychosocial hurdles to improve the decision-making process. During the active treatment phase, Carevive facilitates remote symptom monitoring through electronic patient-reported outcomes (ePROs), providing tailored symptom management strategies and evidence-based pathways that strive to improve quality of life and reduce hospitalizations. Even after treatment is completed, the platform continues to track patient-reported late effects and organizes necessary care, including diagnostic evaluations to detect new or recurring cancers. In addition, Carevive's analytical tools offer valuable insights derived from aggregated patient experience data, which support continuous quality improvement and contribute to actionable research in the field of oncology. This all-encompassing approach guarantees that patients receive thorough support throughout their cancer journey, significantly enhancing their overall health outcomes and well-being. By prioritizing both physical and emotional aspects of care, Carevive ensures a more patient-centered experience that can adapt to individual needs over time.

Brainlab's Elements Contrast Clearance Analysis utilizes MRI technology to effectively differentiate between areas of contrast clearance and accumulation in brain tumor imaging datasets. This sophisticated high-resolution technique significantly improves the insight required for ongoing assessments and decision-making in various medical specialties, such as radiosurgery, radiation oncology, neurosurgery, neuro-oncology, and neuroradiology. The process involves obtaining two standard 3D T1-weighted MRIs; the first is captured approximately five minutes after the injection of a standard contrast agent, followed by a second scan taken between 60 to 105 minutes later. By performing a subtraction of the first series from the latter, volumetric maps are generated that distinctly highlight regions of contrast clearance (depicted in blue) and those of contrast accumulation (marked in red). This information empowers healthcare professionals to more accurately gauge the impacts of radiation therapy against the possibility of tumor regrowth, thus facilitating more informed decisions regarding both initial and ongoing treatment strategies. Consequently, this analytical approach not only supports clinical evaluations but also plays a crucial role in enhancing the overall management of patient care in challenging medical scenarios, ultimately leading to improved patient outcomes.

Aissel Technologies is a B2B SaaS company operating at the intersection of artificial intelligence and life sciences strategy. The company develops intelligent software tools that help life sciences teams make better decisions about who to engage, when, and why. Aissel's flagship product, konectar, is used by teams across pharma, biotechnology firms, medtech, and other life science companies to identify and manage relationships with Key Opinion Leaders (KOLs) and Healthcare Professionals (HCPs) globally. The platform analyses data from clinical trials, peer-reviewed publications, HCP payment databases, conference records, and social media activity to generate a dynamic and precise view of the medical landscape. The konectar product suite includes: • konectar — Core KOL identification, profiling, and engagement platform • konectar Events — Tracking upcoming Medical conferences, Pre/post-congress intelligence • konectar Social — Digital opinion leader tracking and social listening • konectar CRM — HCP engagement management and compliance tracking Aissel serves clients ranging from emerging biotech companies to global pharmaceutical enterprises, with coverage across 20+ therapeutic areas and 150,000+ global medical events tracked annually.

Transform your scattered health information into a cohesive and accessible format with an interactive AI and NLP platform that delivers critical health insights for a diverse range of stakeholders. This cutting-edge technology benefits Providers by expediting the data abstraction process and validating clinical information within notes, which in turn reduces the time and expenses linked to pinpointing care gaps, evaluating care quality through dashboards, and generating registry reports. For Payers, it enhances the integration and analysis of claims data alongside clinical notes, thereby improving the management of high-risk and high-cost member populations. In the Life Sciences sector, this solution accelerates patient matching for clinical trials by utilizing both databases and clinical note data, effectively tapping into the potential of real-world clinical evidence. Ember seamlessly combines NLP with predictive analytics, optimizing healthcare analytics for unstructured data to enhance quality, efficiency, and outcomes throughout the healthcare system. Consequently, stakeholders are empowered to make well-informed decisions that not only elevate patient care but also optimize resource allocation for better healthcare delivery. Ultimately, this holistic approach fosters a more connected and efficient healthcare ecosystem.

DoseMeRx is recognized as the world’s first and largest Bayesian dosing platform, specifically designed for clinical applications. Our advanced platform expedites your path to achieving clinical goals while significantly improving patient outcomes and minimizing costs. Distinctively, we are the only Bayesian dosing solution in the world that possesses HITRUST certification, ensuring that patient data is safeguarded with the highest standards of protection and integrity. Benefit from uninterrupted continuity of care across your healthcare system through a few straightforward steps. You can effortlessly standardize your workflows and optimize your therapeutic drug monitoring strategies. Our extensive range of drug models covers various therapeutic areas, including vancomycin and infectious diseases, transplant medicine, cardiovascular and coagulation care, as well as oncology and pediatrics, providing comprehensive support for numerous clinical situations. This adaptability not only enhances the quality of care but also enables healthcare professionals to offer personalized treatment options with greater efficiency. Ultimately, DoseMeRx empowers providers to meet the unique needs of their patients, fostering improved health outcomes across diverse populations.

Evolent Care Partners, a healthcare provider based in the Midwest, has achieved notable progress in both clinical and administrative performance, securing the impressive position of third nationally for total shared savings and the percentage of savings relative to benchmarks. By equipping independent primary care physicians with vital resources and capital, Evolent Care Partners enables them to successfully navigate and flourish under two-sided payer contracts, thus reducing their financial risks. In the realm of oncology and cardiology, New Century Health improves cost-effectiveness and care quality by utilizing clinical evidence to guide treatment decisions, an approach that garners support from both payers and providers. Additionally, Evolent Health Services enhances the efficiency of health plan operations with a comprehensive suite of services built on a modern, integrated platform and a commitment to strategic partnership. The organization also promotes the exploration of insights and updates related to value-based care, population health, and health plan management, reflecting its dedication to healthcare transformation. Overall, through these collective efforts, Evolent aspires to create a more streamlined and effective healthcare environment for all stakeholders involved.

The Innovaccer Health Cloud is designed to propel your transformation journey forward. By consolidating patient information, it enables the generation of in-depth financial and clinical insights while fostering quicker innovation. Our platform assists healthcare providers in merging various patient data sources to deliver actionable insights directly at the point of care, ensuring improved collaboration among care teams and ultimately enhancing patient outcomes. We enhance connectivity and teamwork among payers, providers, and members, allowing for effective risk management, compliance adherence, and meeting the growing expectations of members. Additionally, we support medtech and biopharma companies in developing digital solutions that bridge the gap between healthcare and the optimization of real-world data throughout the entire value chain. This transformation shifts the focus from isolated systems to a unified platform, creating a comprehensive longitudinal patient record that promotes holistic care for individuals while streamlining healthcare delivery. Embrace this shift to realize the full potential of integrated healthcare.

Leverage analytical insights to reduce variability, improve care quality, optimize care coordination, and effectively manage financial results. Whether operating under a fee-for-service model or a risk-based approach, the exceptional data and analytics capabilities, along with expert assistance from Optum® Performance Analytics, empower your organization to prosper in the ever-evolving healthcare landscape. Optum Performance Analytics offers a thorough longitudinal view of clinical and financial data related to your patients, healthcare providers, facilities, and networks. By integrating diverse clinical and claims information with a growing collection of sociodemographic, behavioral, and patient-reported data, you can achieve greater understanding and context. Moreover, Optum Performance Analytics is crafted to be flexible enough to meet the goals of any healthcare organization. For those seeking targeted guidance, pre-built dashboards and opportunity reports are available to pinpoint areas for care enhancement and cost reduction, ultimately enabling the development of more effective health management strategies. This adoption of advanced analytics tools not only promotes improved patient outcomes but also enhances the operational efficiency of healthcare providers, ensuring that they can navigate challenges with greater confidence and agility. As a result, organizations can utilize these insights to create a more sustainable and impactful healthcare delivery system.

Regardless of the size of your clinic or its geographical position, MOSAIQ Plaza* provides you with vital digital resources to deliver outstanding multidisciplinary care for your patients, ensuring their journey from diagnosis to survivorship is marked by consistency, reliability, and security while also producing valuable real-world evidence. Elekta has rolled out comprehensive solution packages aimed at enhancing your team's capability to deliver care and refine treatment workflows, enabling you to focus on what truly matters: your patients. As we forge ahead into the future of multidisciplinary cancer care, MOSAIQ 3 sets new standards in oncology workflow and information management. By utilizing the seamless accessibility of the MOSAIQ Plaza environment, you will witness significant efficiencies and a more streamlined operational process, which ultimately boosts patient outcomes and satisfaction. This commitment to innovation not only transforms care delivery but also empowers healthcare professionals to excel in their roles.

Sargas Pharmaceutical Adherence and Compliance (SPAC) International has developed an advanced Chronic Care Management Cloud® platform (CCM), along with its Drug Adherence®, Medication Therapy Monitoring® (MTM), and Mobile Oncology Medication Therapy Monitoring® solutions, to foster ongoing interaction between healthcare providers and patients from the beginning of treatment through its entirety. This integrated approach to treatment management not only aids patients in optimizing their health benefits and achieving the best possible results but also plays a significant role in reducing overall healthcare expenses. Furthermore, SPAC provides HIPAA Compliant and certified Chronic Care Management Physician, Patient, and Pharmacy Portals® that enable the instantaneous sharing of vital health information among different healthcare professionals, thereby ensuring a smooth flow of critical data necessary for effective treatments. Such technological innovations significantly improve the quality of care that patients receive, reinforcing the importance of collaboration in healthcare. Ultimately, this commitment to continuous engagement and information exchange sets a new standard for patient-centered care.

Our extensive dataset of primary sources is unparalleled in its diversity and depth, serving as a critical resource for professionals in the healthcare field who seek to uncover valuable insights that can improve health results and economic performance. By leveraging relevant data extracts that cover a broad range of care, including precise provider identification and a holistic view of the patient experience, healthcare stakeholders can securely link to external datasets, thus driving innovation in the industry. Enhance research initiatives and improve health outcomes through longitudinally linkable, deidentified real-world data essential for making well-informed choices. We perform over 1,100 thorough data integrity assessments to ensure accuracy and consistency, utilizing industry-standard practices for quality assurance and smooth integration. Discover groundbreaking insights through our rich and relevant real-world data offerings. Furthermore, by utilizing customized extracts from both open and proprietary primary sources, researchers can streamline their efforts and advance clinical results while also evaluating provider performance. Our unwavering dedication to data quality and relevance empowers healthcare professionals to make optimal decisions, ultimately fostering a healthier future for all. In this rapidly evolving landscape, the use of our dataset positions researchers at the forefront of healthcare innovation.

Elevate the experiences of patients and enhance health results while driving the efficacy of medical practices in the rapidly changing oncology sector. Canopy’s Intelligent Care Platform offers a robust collection of interoperable software tools that integrate effortlessly with electronic medical records and practice management systems, empowering healthcare providers to deliver exceptional care to a wider array of patients at lower expenses. Increase revenue by extending treatment durations and adeptly executing reimbursement methods, all while enhancing quality metrics within the practice. Our remote monitoring capabilities, triage algorithms, and symptom management protocols play a crucial role in improving patient outcomes and enriching overall quality of life. Moreover, we refine incoming call processes, which leads to better task management and promotes collaboration among different departments and locations, resulting in a seamless and efficient patient care experience. This comprehensive approach ensures that healthcare professionals can meet the dynamic needs of their patients effectively.

Suvoda stands as a prominent player in the arena of clinical trial technology, concentrating on complex, life-saving research in areas such as oncology, central nervous system disorders, and rare diseases. Founded in 2013, the organization offers a robust platform equipped with Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all designed to optimize critical patient engagements. Their cutting-edge software ensures a seamless user experience, facilitating precise randomization, effective drug supply management, and prompt data gathering. Committed to enhancing patient comprehension and reducing the burdens faced by trial sites, Suvoda's solutions are crafted to adapt to the growing intricacies of clinical research. Headquartered near Philadelphia, with additional branches throughout Europe and Asia, Suvoda has proudly aided in the execution of over 1,500 trials across more than 85 countries, demonstrating their extensive global influence and proficiency in the industry. Their unwavering focus on innovation and high standards establishes them as an essential ally in the progress of clinical research, paving the way for future breakthroughs and transformations in the field.

Foundations™ seamlessly combines financial, clinical, and operational data into a unified platform, which is easily navigable by all team members through an intuitive visualization interface. This innovative tool not only illuminates new operational insights but also enables clinicians, staff, and administrators to monitor dashboards that highlight inefficiencies and pinpoint essential actions to improve patient care while also driving business success. Serving as the definitive “source of truth,” Foundations™ empowers every team member to make well-informed decisions with assurance. By refining documentation quality across various domains, including workflow statuses and case specifics, the platform significantly reduces complication rates for each case. Consequently, patients benefit from enhanced clinical outcomes overall. Additionally, Foundations™ effectively empowers clinicians by presenting real-time operational data in an engaging format, which facilitates prompt action and ultimately enhances patient health outcomes. Moreover, it offers clinicians a swift, efficient method to assess their performance in comparison to peers and set benchmarks, promoting a deeper grasp of clinical metrics and encouraging ongoing advancement. This comprehensive strategy guarantees that all team members work cohesively towards the dual goals of optimizing patient care and improving operational effectiveness, thereby creating a more efficient healthcare environment. Ultimately, this integration of data and collaboration fosters a culture of continuous quality improvement across all levels of the organization.

We support the shift towards value-based healthcare by assessing a range of treatments, medications, processes, and costs, which assists hospitals, life sciences companies, and insurance providers in identifying treatment approaches that result in the best patient outcomes. Our CRCA™ P&T platform empowers P&T committees to make data-informed improvements in quality measures, including average length of stay (ALOS) and 30-day readmission rates. Moreover, our cutting-edge POP-BUILDER Rx™ solution presents comparative insights between selected groups and CRCA's vast database of real-world data, which includes over 140 million longitudinal patient records. In addition, our drug remittance dashboard thoroughly examines and reports on drug remittance details across various payer categories, with a focus on high-cost medications down to the National Drug Code (NDC) level. We also enable hospital finance teams to effectively monitor and improve service line costs, profitability, productivity, and revenue cycle performance through our detailed analytics and reporting, along with the support of our Agilum Healthcare Intelligence team. This ensures healthcare providers can make well-informed decisions that enhance their operations and patient care. By integrating these diverse resources, we create a comprehensive understanding of the complex financial and clinical environment in which healthcare providers function, ultimately aiming to improve overall healthcare delivery.

Oncology-Cloud, created by WRS Health, goes beyond standard EHR and Practice Management systems by providing a holistic platform designed by healthcare experts. This all-in-one solution emphasizes clinician-focused processes, with the goal of continually improving and growing your practice. Moreover, the platform’s Business Process Outsourcing (BPO) service employs a consultative method, working alongside you and your staff to evaluate and set specific KPIs for your practice. Utilizing our proven methodology, we assist you in achieving these goals while enhancing your operational efficiency. By fostering a collaborative relationship, we help ensure your practice flourishes in an ever-evolving healthcare environment, ultimately leading to better patient care and satisfaction. The commitment to your success is at the forefront of our approach, making us a valuable ally in navigating the complexities of modern healthcare.

Mahalo Health is a comprehensive digital health platform designed to accelerate the development of patient-centered digital health solutions and clinical trials. It offers an array of prebuilt modules that enable the rapid deployment of customizable white-label applications tailored to specific therapeutic areas. The platform is equipped with advanced data capabilities, which include a predictive health engine for anticipating diseases and diagnoses, a behavior modification engine that promotes healthy patient habits, and a notification system that guarantees prompt communication via push notifications, SMS, or emails. Mahalo Health is dedicated to upholding rigorous security and compliance standards, adhering to regulations like HIPAA, GCP, ISO27001, and GDPR. Its diverse service offerings span various therapeutic domains, such as diabetes management, cognitive health, cardiovascular care, musculoskeletal issues, mental well-being, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Furthermore, Mahalo Health not only enhances patient engagement but also improves health outcomes by equipping healthcare providers with innovative digital tools and solutions that adapt to the evolving needs of their patients. This commitment to innovation ensures that healthcare delivery is both efficient and personalized.